179 related articles for article (PubMed ID: 30372570)
1. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway.
Chen YT; Yang CC; Shao PL; Huang CR; Yip HK
J Pineal Res; 2019 Jan; 66(1):e12536. PubMed ID: 30372570
[TBL] [Abstract][Full Text] [Related]
2. Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation and Growth through Inhibiting PrP
Yang CC; Chuang FC; Chang CL; Huang CR; Chen HH; Yip HK; Chen YT
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834767
[TBL] [Abstract][Full Text] [Related]
3. Jagged2 progressively increased expression from Stage I to III of Bladder Cancer and Melatonin-mediated downregulation of Notch/Jagged2 suppresses the Bladder Tumorigenesis
Chen YT; Huang CR; Chang CL; Chiang JY; Luo CW; Chen HH; Yip HK
Int J Biol Sci; 2020; 16(14):2648-2662. PubMed ID: 32792862
[No Abstract] [Full Text] [Related]
4. ZNF746 plays cardinal roles on colorectal cancer (CRC) cell invasion and migration and regulates mitochondrial dynamics and morphological changes of CRC cells-Role of combined melatonin and 5-FU regimen.
Huang CR; Chu YT; Chang CL; Yip HK; Chen HH
J Cell Biochem; 2024 Feb; 125(2):e30507. PubMed ID: 38047497
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
6. Flaccidoxide-13-Acetate Extracted from the Soft Coral Cladiella kashmani Reduces Human Bladder Cancer Cell Migration and Invasion through Reducing Activation of the FAK/PI3K/AKT/mTOR Signaling Pathway.
Neoh CA; Wu WT; Dai GF; Su JH; Liu CI; Su TR; Wu YJ
Molecules; 2017 Dec; 23(1):. PubMed ID: 29280977
[TBL] [Abstract][Full Text] [Related]
7. TG-interacting factor-induced superoxide production from NADPH oxidase contributes to the migration/invasion of urothelial carcinoma.
Huang HS; Liu ZM; Chen PC; Tseng HY; Yeh BW
Free Radic Biol Med; 2012 Aug; 53(4):769-78. PubMed ID: 22728270
[TBL] [Abstract][Full Text] [Related]
8. The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion.
Schneider L; Liu J; Zhang C; Azoitei A; Meessen S; Zheng X; Cremer C; Gorzelanny C; Kempe-Gonzales S; Brunner C; Wezel F; Bolenz C; Gunes C; John A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070905
[TBL] [Abstract][Full Text] [Related]
9. Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
Dong Q; Fu L; Zhao Y; Tan S; Wang E
Oncotarget; 2017 Mar; 8(10):17059-17069. PubMed ID: 28178653
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
11. Sinulariolide Suppresses Cell Migration and Invasion by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase through the PI3K/AKT/mTOR Signaling Pathway in Human Bladder Cancer Cells.
Cheng TC; Din ZH; Su JH; Wu YJ; Liu CI
Mar Drugs; 2017 Aug; 15(8):. PubMed ID: 28767067
[TBL] [Abstract][Full Text] [Related]
12. 5‑bromo‑3‑(3‑hydroxyprop‑1‑ynyl)‑2H‑pyran‑2‑one induces apoptosis in T24 human bladder cancer cells through mitochondria-dependent signaling pathways.
Yu GQ; Dou ZL; Jia ZH
Mol Med Rep; 2017 Jan; 15(1):153-159. PubMed ID: 27922685
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
Li Y; Shan Z; Liu C; Yang D; Wu J; Men C; Xu Y
Biochemistry (Mosc); 2017 Apr; 82(4):474-482. PubMed ID: 28371605
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated vascular endothelial growth factor-C reduction suppresses malignant progression and enhances mitomycin C sensitivity of bladder cancer T24 cells.
Zhang HH; Qi F; Shi YR; Miao JG; Zhou M; He W; Chen MF; Li Y; Zu XB; Qi L
Cancer Biother Radiopharm; 2012 Jun; 27(5):291-8. PubMed ID: 21902544
[TBL] [Abstract][Full Text] [Related]
15. Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.
Noguchi S; Yasui Y; Iwasaki J; Kumazaki M; Yamada N; Naito S; Akao Y
Cancer Lett; 2013 Jan; 328(2):353-61. PubMed ID: 23104321
[TBL] [Abstract][Full Text] [Related]
16. Loss of Mel-18 induces tumor angiogenesis through enhancing the activity and expression of HIF-1α mediated by the PTEN/PI3K/Akt pathway.
Park JH; Lee JY; Shin DH; Jang KS; Kim HJ; Kong G
Oncogene; 2011 Nov; 30(45):4578-89. PubMed ID: 21602890
[TBL] [Abstract][Full Text] [Related]
17. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
18. Tianeptine sodium salt suppresses TNF-α-induced expression of matrix metalloproteinase-9 in human carcinoma cells via suppression of the PI3K/Akt-mediated NF-κB pathway.
Jayasooriya RG; Dilshara MG; Choi YH; Moon SK; Kim WJ; Kim GY
Environ Toxicol Pharmacol; 2014 Sep; 38(2):502-9. PubMed ID: 25168152
[TBL] [Abstract][Full Text] [Related]
19. 5-Aza-2'-deoxycytidine enhances maspin expression and inhibits proliferation, migration, and invasion of the bladder cancer T24 cell line.
Zhang H; Qi F; Cao Y; Zu X; Chen M; Li Z; Qi L
Cancer Biother Radiopharm; 2013 May; 28(4):343-50. PubMed ID: 23570371
[TBL] [Abstract][Full Text] [Related]
20. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells.
Li HL; Zhang S; Wang Y; Liang RR; Li J; An P; Wang ZM; Yang J; Li ZF
Mol Med Rep; 2013 Jan; 7(1):266-70. PubMed ID: 23064738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
